Study to Investigate Safety and Tolerability of Intravenous Lacosamide in Children.
Status:
Completed
Trial end date:
2019-06-28
Target enrollment:
Participant gender:
Summary
EP0060 is a multicenter, open-label study to evaluate the safety and tolerability of
intravenous (iv) Lacosamide (LCM) in pediatric subjects >= 1 month to < 17 years of age with
epilepsy.